How to treat MS in 2014: treat-2-target and prevent end-organ damage. #MSBlog #MSResearch
"As promised the following is my presentation from yesterday at the Imperial College MS Study Day. My talk generated a lot of questions about the new treatment paradigm of treating-2-target and preventing end-organ damage in MS. It will be interesting to see of the wider MS community adopt this approach."
Labels: Imperial College, NEDA, treat-2-target